Table 1.

Experimental groups and procedures

Experimental group	Procedure
Basic control group, BCG	No stroke, no treatment
Stroke control group, SCG	Stroke with 0.9 % NaCl 2 h poststroke
rt-PA monotherapy	Stroke with rt-PA (10 mg/kg b.w.)
Masitinib (25 mg/kg) monotherapy	Stroke with masitinib only (25 mg/kg b.w. twice per day)
Masitinib (25 mg/kg) rt-PA combination	Stroke with rt-PA (10 mg/kg b.w.) plus masitinib (25 mg/kg b.w. twice per day)
Masitinib (100 mg/kg) monotherapy	Stroke with masitinib only at 100 mg/kg b.w. (twice per day)
Masitinib (100 mg/kg) rt-PA combination	Stroke with rt-PA (10 mg/kg b.w.) plus masitinib (100 mg/kg b.w. twice per day)

b.w. body weight, rt-PA recombinant tissue plasminogen activator